BASF Extends Kollicoat Excipient Line
Kollicoat MAE 100-55 from BASF can be used as a direct substitute in commercial enteric pharmaceutical formulations.
Kollicoat MAE 100-55, introduced by BASF on April 4, 2016, is a functional excipient for instant and modified release drugs that can replace comparable pH >5.5 enteric release materials in commercial formulations, the company reports. The coating polymer matches the release profile and complies with applicable regulatory monographs and can be used without re-registration.
The size of the dried powder particles delivers dust-free handling, and the product provides equivalent drug release as existing comparable products in the market, according to a company statement.
Kollicoat MAE 100-55 extends the company’s pH >5.5 enteric release coatings based on methacrylic acid-ethylacrylate copolymer.
Source: BASF
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
